Related Experiment Video

Updated: Jun 26, 2026

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice
10:04

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Published on: December 2, 2022

Regression of liver cirrhosis

Jonathan Andrew Fallowfield1, Prakash Ramachandran1, Timothy James Kendall2

  • 1Centre for Inflammation Research, Institute of Regeneration & Repair, University of Edinburgh, Edinburgh, UK.

Journal of Hepatology
|June 24, 2026
PubMed

Insights

Cirrhosis is a dynamic liver disease, not a fixed end-stage. Understanding the scar

Area of Science:

  • Hepatology and liver disease research.
  • Cellular and molecular biology of fibrotic diseases.

Background:

  • Global cirrhosis prevalence and mortality are increasing significantly.
  • Cirrhosis, once considered irreversible, is now recognized as a dynamic and potentially modifiable condition.
  • Liver transplantation is the only cure for advanced cirrhosis, highlighting the need for alternative therapeutic strategies.

Purpose of the Study:

  • To explore the dynamic nature of cirrhosis and its potential for regression.
  • To investigate the factors influencing cirrhosis reversibility beyond fibrosis stage.
  • To address the challenges in translating mechanistic insights into effective cirrhosis therapies.

Main Methods:

  • Analysis of single-cell and spatial data to characterize fibrotic niches.
  • Evaluation of fibrogenic, immune, and vascular cell phenotypes in cirrhosis.
  • Review of recent antifibrotic trial outcomes, particularly in MASH-related cirrhosis.

Main Results:

  • Cirrhosis is a heterogeneous fibrotic niche influenced by specific cell phenotypes.
  • Reversibility depends on the biological state of the scar and microenvironment, not just fibrosis stage.
  • Advanced cirrhosis exhibits structural resilience, and regression does not guarantee full tissue homeostasis or eliminate residual risks.

Conclusions:

  • Cirrhosis regression is complex, influenced by the microenvironment and cellular phenotypes.
  • Current histological endpoints may lack sensitivity for assessing therapeutic efficacy in advanced cirrhosis.
  • Developing precise measurement tools and therapies for cirrhosis regression is a critical challenge in hepatology.

Keywords:
Liver fibrosisantifibrotic therapycirrhosisextracellular matrix remodellinghepatic stellate cellsmacrophagesnon-invasive biomarkersregression

More Related Videos

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Procedure07:29

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Procedure

Published on: August 14, 2017

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...